Sign in Pull a receipt

ARGX

ARGENX SE

Biotechnology · Biotechnology

$76.03 sample

+0.18 (+0.24%) 1D

Market cap

$328.4B

Price as of

2026-10-25

Latest filing

8-K · 2026-10-14

Alerts

8

Price$76.03 +10.96% 3M daily closessample

77.9268.52

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: Chief Financial Officer
Oct 14SEC8-K filed: material event
Oct 09INSInsider sell: Chief Financial Officer
Oct 02INSInsider sell: Director
Sep 23INSInsider buy: Director
Sep 18INSInsider sell: General Counsel
Sep 14INSInsider sell: Chief Executive Officer
Sep 07INSInsider sell: 10% owner

Sign up to see the real ARGX record →

Company facts

SEC EDGAR registration

Name: ARGENX SE
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -52sample, -100 to +100
Reporting currency: USD

Who is positioning in ARGX

sample

Insiders: 12 insider transactions over 90 days, net selling, $194.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 44 funds hold $7.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.4B +22.5% y/y

Q4 2024Q3 2026

Inventory$10.2B +10.1% y/y

Q4 2024Q3 2026

Accounts receivable$7.8B +17.4% y/y

Q4 2024Q3 2026

Total debt$20.4B +12.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $216.7B +1.9% 3M
Sample peer B: $90.3B -13.0% 3M
Sample peer C: $167.0B -6.7% 3M
Sample peer D: $141.5B +1.2% 3M
Sample peer E: $297.4B +4.9% 3M